Skip to main navigation Skip to search Skip to main content

A phase I/II trial of the interleukin-6 receptorspecific humanized monoclonal (tocilizumab) + intravenous immunoglobulin in difficult to desensitize patients

  • Ashley A. Vo
  • , Jua Choi
  • , Irene Kim
  • , Sabrina Louie
  • , Kristen Cisneros
  • , Joseph Kahwaji
  • , Mieko Toyoda
  • , Shili Ge
  • , Mark Haas
  • , Dechu Puliyanda
  • , Nancy Reinsmoen
  • , Alice Peng
  • , Rafael Villicana
  • , Stanley C. Jordan

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)2356-2363
Number of pages8
JournalTransplantation
Volume99
Issue number11
DOIs
StatePublished - Nov 2015
Externally publishedYes

ASJC Scopus Subject Areas

  • Transplantation

Keywords

  • Drug Administration Schedule
  • Histocompatibility Testing
  • Histocompatibility/drug effects
  • Humans
  • Middle Aged
  • Immunosuppressive Agents/administration & dosage
  • Male
  • Treatment Outcome
  • Kidney Transplantation/adverse effects
  • Pilot Projects
  • Time Factors
  • Antibodies, Monoclonal, Humanized/administration & dosage
  • Graft Survival/drug effects
  • Immunoglobulins, Intravenous/administration & dosage
  • Isoantibodies/blood
  • Adult
  • Biomarkers/blood
  • Female
  • Los Angeles
  • Drug Therapy, Combination
  • Graft Rejection/blood
  • Desensitization, Immunologic/adverse effects

Cite this